Preventive Medicine Physician - Remote AI Clinical Auditor

Labela; Texas; Remote; USD 180,000 - 240,000; Part time

Job summary

Labela is seeking U.S.-based Preventive Medicine Physicians at all career stages for high-level clinical consulting to validate and audit AI-driven medical reasoning. This is a flexible, remote role designed to influence the safety and accuracy of frontier AI models at scale.

You will serve as a subject matter expert, refining AI outputs and ensuring alignment with ACPM standards. The engagement runs July 30 to August 31, 2026, with Texas-focused cohort prioritization while remaining fully

Qualifications

• Board-certified or board-eligible in Preventive Medicine (ABPM).
• 2+ years of postgraduate clinical training.
• Based in the United States.
• Ability to provide concise, technical feedback on complex clinical cases.

Responsibilities

• Clinical Logic Auditing: Review and refine AI-generated diagnostic and treatment strategies to ensure alignment with ACPM standards.
• High-Complexity Validation: Provide expert-level ground truth for intricate preventive and population-health case presentations.
• Safety Oversight: Identify clinical inaccuracies or hallucinations in AI outputs that could impact patient safety or triage decisions.
• Strategic Consulting: Advise on the development of AI-driven clinical decision support tools for preventive and population-health care.

Skills

Concise feedback

Technical feedback

Education

Preventive Medicine board certification (ABPM)

Preventive Medicine board-eligible (ABPM)

Senior resident or fellow training (PGY-2+)

Job description

Labela is seeking U.S.-based Preventive Medicine Physicians at all career stages for high-level clinical consulting to validate and audit AI-driven medical reasoning. This is a flexible, remote role designed to influence the safety and accuracy of frontier AI models at scale.

You will serve as a subject matter expert, refining AI outputs and ensuring alignment with ACPM standards. The engagement runs July 30 to August 31, 2026, with Texas-focused cohort prioritization while remaining fully